Weak symptoms of bacterial endophthalmitis after a triamcinolone acetonide-assisted pars plana vitrectomy

Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
Takehiro YamashitaTaiji Sakamoto

Abstract

To report a case of endophthalmitis after triamcinolone acetonide (TA)-assisted par plane vitrectomy (PPV). A 60-year-old Japanese man developed endophthalmitis after TA-assisted PPV for diabetic macular edema. Preoperative visual acuity was 20/200. Four days after surgery, endophthalmitis associated with anterior chamber hypopyon was noticed; the patient's vision had deteriorated to hand motion. In spite of severe cell infiltration, the ciliary injection and ocular pain were not significant. The additional PPV with irrigation of cefazolin (40 microg/ml) and gentamicin (8 microg/ml) was performed. Endophthalmitis resolved soon after this treatment. Staphylococcus epidermidis was detected in the intravitreous samples. The patient's visual acuity improved to 20/100. Endophthalmitis may be a complication of TA-assisted PPV with unique signs and symptoms.

Citations

May 26, 2005·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·I KreissigJ B Jonas
Jun 23, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Taiji Sakamoto, Tatsuro Ishibashi
Mar 30, 2007·International Ophthalmology·Shinsuke AtakaKunihiko Shiraki
Apr 3, 2007·Journal of Cataract and Refractive Surgery·Sang Mok LeeKyu Hyung Park
Jul 6, 2004·American Journal of Ophthalmology·Taiji SakamotoTatsuro Ishibashi
Dec 21, 2005·Japanese Journal of Ophthalmology·Yoshinori MitamuraKenji Ohtsuka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.